Qinglin Li
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 6
- Physiology top 2%
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 6
- Molecular Biology top 5%
- Natural product bioactivities and synthesis 7
- RNA modifications and cancer 6
-
- Natural Compound Pharmacology Studies 8
-
- Autophagy in Disease and Therapy 7
-
- Biological and pharmacological studies of plants 5
- Co-authors
- Xuncui WangGuoqi ZhuGabriel EadesYuan YaoYongshu ZhangEsteban A. RobertsChihiro AkazawaChengyu Liang
- Journals
- Journal of Biological Chemistry (2 papers)Journal of Neuroscience (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Qinglin Li
79 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 681
- Physiology 164
- Complementary and alternative medicine 203
- Neurology 201
- Molecular Biology 1.7k
Countries citing papers authored by Qinglin Li
This map shows the geographic impact of Qinglin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Li more than expected).
Fields of papers citing papers by Qinglin Li
This network shows the impact of papers produced by Qinglin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Li. The network helps show where Qinglin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Qinglin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 10 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 6 | |
| 11 | 2023 | 4 | |
| 12 | 2022 | 36 | |
| 13 | 2019 | 69 | |
| 14 | 2019 | 23 | |
| 15 | 2014 | 208 | |
| 16 | Gastrodin Protects PC12 Cells from Glutamate Toxicity by Down-regulating ERK1/2 and p38 Pathways | 2013 | 1 |
| 17 | Gambogenic acid induced apoptosis in human nasopharyngeal carcinoma CNE-1 cells and effect of p-p38 and p-ERK1/2 protein | 2011 | 1 |
| 18 | 2011 | 68 | |
| 19 | Antitumor effects of neogambogic acid both in vivo and in vitro | 2008 | 3 |
| 20 | 2008 | 80 |
About Qinglin Li
Qinglin Li is a scholar working on Cancer Research, Geriatrics and Gerontology and Neurology, having authored 86 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), Natural Compound Pharmacology Studies (8 papers), Natural product bioactivities and synthesis (7 papers), Autophagy in Disease and Therapy (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (6 papers), RNA modifications and cancer (6 papers), MicroRNA in disease regulation (6 papers) and Biological and pharmacological studies of plants (5 papers). The work is most often cited by research in Cancer Research (681 citations), Physiology (164 citations) and Complementary and alternative medicine (203 citations). Qinglin Li has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Xuncui Wang, Guoqi Zhu, Gabriel Eades, Yuan Yao, Yongshu Zhang, Esteban A. Roberts, Chihiro Akazawa, Chengyu Liang, Vojo Deretić and Kyung‐Soo Inn. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.